
Migrafin P 40mg/10mg Capsule
Marketer
Leeford Healthcare Ltd
Salt Composition
Propranolol (40mg) + Flunarizine (10mg)
Overview Migrafin P 40mg/10mg Capsule
Combifin 40mg/10mg capsules offer preventative migraine management through a dual-medication approach. This formulation isn't intended for immediate migraine relief. Optimal absorption occurs on an empty stomach; consistent daily dosing, ideally at bedtime, is recommended. Dosage frequency is individualized based on your needs; your physician determines the appropriate regimen to manage your condition. Continue this medication as directed. Lifestyle adjustments, such as stress reduction, smoking cessation, and limiting processed foods, can enhance its effectiveness. Potential side effects include weight increase, bradycardia, lethargy, depressive symptoms, somnolence, and cold extremities. Drowsiness may occur; avoid driving or tasks requiring alertness, and rise cautiously from a seated position. This medication can mask hypoglycemia; regular blood glucose and blood pressure monitoring is essential. Inform your doctor of any pre-existing liver or kidney disease, depression, pregnancy, or breastfeeding before commencing treatment. Fully disclose all other medications you're using, as interactions may compromise efficacy or alter the drug's action.
Uses of Migrafin P 40mg/10mg Capsule
Migraine Prevention Strategies
Major Benefits of Migrafin P 40mg/10mg Capsule:
Administer this medication precisely as prescribed by your physician regarding dosage and treatment length. Consume Migrafin P 40mg/10mg Capsules on an empty stomach.
Common Side effects of Migrafin P 40mg/10mg Capsule:
- Weight gain
- Slow heart rate
- Tiredness
- Depression
- Drowsiness
- Abnormal dreams
- Cold extremities
How to use Migrafin P 40mg/10mg Capsule:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest Migrafin P 40mg/10mg Capsules on an empty stomach.
How Migrafin P 40mg/10mg Capsule works:
Migrafin P 40mg/10mg capsules combine propranolol, a beta-blocker, and flunarizine, a calcium channel blocker, to prevent migraine attacks. This dual action stabilizes overactive nerve cells, raising the threshold for migraine initiation. Furthermore, the combination suppresses cortical spreading depression, the electrical brain activity linked to migraine pain and inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Migrafin P 40mg/10mg Capsules is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Migrafin P 40mg/10mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Migrafin P 40mg/10mg capsules with breastfeeding are lacking. Seek medical advice.
DrivingUNSAFE
Driving may be impaired by Migrafin P 40mg/10mg Capsules, which can induce side effects such as visual disturbances, hallucinations, fatigue, cognitive impairment, dizziness, or drowsiness.
KidneySAFE IF PRESCRIBED
The use of Migrafin P 40mg/10mg Capsules in individuals with kidney disease appears to pose minimal risk. Preliminary findings indicate that dose modification may be unnecessary; however, medical advice is recommended.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Migrafin P 40mg/10mg capsules. Dosage modification of Migrafin P 40mg/10mg capsules may be necessary. Physician consultation is recommended. Routine blood pressure checks are suggested to guide dosage changes.
What if you forget to take Migrafin P 40mg/10mg Capsule :
Should you forget to take a Migrafin P 40mg/10mg Capsule, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Migrafin P 40mg/10mg Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
